{"schema_version":"secwatch.filing_event.v1","accession":"0001826470-26-000045","form_type":"8-K","ticker":"WOOF","cik":"0001826470","company_name":"Petco Health & Wellness Company, Inc.","filed_at":"2026-06-03T20:10:18+00:00","discovered_at":"2026-06-03T20:11:00.181735+00:00","generated_at":"2026-06-03T20:39:32.590128+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Petco Q1 comps +0.7%, adj. EBITDA $97.3M; reaffirms FY 2026 outlook","bullets":["Net sales of $1.5B, +0.2% YoY; comparable sales +0.7%, marking return to positive comps.","Gross margin improved 21bps to 38.4%; operating income rose 50.5% to $24.6M.","Adj. EBITDA $97.3M vs $89.4M; net loss widened to $15.1M from $11.7M.","Total debt reduced to $1.482B from $1.593B; cash balance $166.8M.","FY 2026 outlook reaffirmed: net sales flat to +1.5%, adj. EBITDA $415M-$430M; Q2 adj. EBITDA guided $110M-$112M."],"urls":{"canonical":"https://secwatch.observer/filing/0001826470-26-000045","json":"https://secwatch.observer/filing/0001826470-26-000045.json","markdown":"https://secwatch.observer/filing/0001826470-26-000045.md","text":"https://secwatch.observer/filing/0001826470-26-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826470/000182647026000045/0001826470-26-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826470/000182647026000045/woof-20260603.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T20:39:32.590128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91cb6771df87b6ce6591a3beb9b2a2e1bececd7b","claim":"Petco Health & Wellness Company, Inc. updated its fiscal year 2026 guidance (reaffirmed).","evidence_excerpt":"The company reaffirmed its full year 2026 net sales and EBITDA outlook and provided its outlook for the second quarter of 2026.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826470/000182647026000045/0001826470-26-000045-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year 2026"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"ae975ef25a8cdcd6811d81c6b9174b4b39592dd1","claim":"Petco Health & Wellness Company, Inc. reported the quarter ended May 2, 2026 results: revenue $1.5 billion, net income Net loss of $15.1 million.","evidence_excerpt":"Net sales of $1.5 billion increased 0.2%; comparable sales increased 0.7%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826470/000182647026000045/0001826470-26-000045-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended May 2, 2026"},{"label":"Revenue","value":"$1.5 billion"},{"label":"Net income","value":"Net loss of $15.1 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}